An equity transfer involving a China foreign-invested company changes ownership of the company rather than selling each underlying asset.
The legal route can involve company approvals, pre-emption or shareholder rights, foreign-investment access, merger control/NSR where relevant, tax, registration and payment/FX steps. The correct process depends on the company, buyer and transaction structure.
The signal ledger.
These facts move the question beyond a label and into a product, money-flow and control analysis.
Bring a compact evidence docket—not a pitch deck.
Give a compliance team or counsel the operating facts that reveal the perimeter.
Questions people ask before they build.
Short answers for orientation. The right result can change with the service model and current rules.
Do all deals need SAMR merger control?
No. Filing depends on turnover thresholds and deal structure. When thresholds are met, closing without clearance is high risk.
Is negative-list clearance the same as NSR?
No. Market-access (negative list) and national security review are separate screens from antitrust.
Where to go deeper?
Open the Corporate M&A & Exit guide and the SAMR merger control explainer.
Primary authorities
Reviewed sources support orientation, not a fact-specific assessment.
Sources last checked: